Cytology of ileal conduit urine bladder cancer patients

被引:5
作者
Ajit, D [1 ]
Dighe, SB [1 ]
Desai, SB [1 ]
机构
[1] Tata Mem Hosp, Div Cytol, Dept Pathol, Bombay 400012, Maharashtra, India
关键词
ileal conduit; urine; bladder cancer;
D O I
10.1159/000325897
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective To study the cytomorphology of urine obtained from the ileal conduit and to determine its utility and identify the pitfalls. Study Design Urine specimens from 469 cases of suspected or proven bladder cancer received over a period of 5 years were analyzed in the cytology laboratory. In 35 cases, total bladder resection was followed by ileal conduit reconstruction. The follow-up cytologic analysis of these 35 ileal conduit cases formed the basis of this study. Results There was absence of urothelial cells in all but 2 cases. The smear predominantly showed small, scattered intestinal mucosal cells with pyknotic nuclei, extensive karyorrhexis and numerous bacteria. In 2 cases, cytology proved superior to endoscopy and radiology in detecting recurrent disease. We had 2 false negative cases, and the negativity was attributed to sampling errors. There was 1 false positive case in which 3-dimensional clusters of intestinal columnar cells were erroneously diagnosed as adenocarcinoma. Conclusion Urine obtained from ileal conduit specimens shows a smear picture that is different from that of specimens from the bladder. Thus, it is imperative to understand the difference between the cytomorphology of bladder urine and ileal conduit urine, to minimize the pitfalls and increase diagnostic utility.
引用
收藏
页码:70 / 73
页数:4
相关论文
共 50 条
[31]   Bladder tumor antigen assay as compared to voided urine cytology in the diagnosis of bladder cancer [J].
Priolo, G ;
Gontero, P ;
Martinasso, G ;
Mengozzi, G ;
Formiconi, A ;
Pelucelli, G ;
Zitella, A ;
Casetta, G ;
Viberti, L ;
Aimo, G ;
Tizzani, A .
CLINICA CHIMICA ACTA, 2001, 305 (1-2) :47-53
[32]   Comparing direct medical care costs of patients with bladder cancer who received an ileal conduit vs. neobladder in the year following cystectomy [J].
Banegas, Matthew P. ;
Rosetti, Maureen O'Keeffe ;
Gilbert, Scott M. ;
Kwan, Marilyn L. ;
Leo, Michael C. ;
Danforth, Kim N. ;
Bulkley, Joanna ;
Weinmann, Sheila ;
Yi, David K. ;
Lee, Valerie S. ;
Mcmullen, Carmit .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (04) :267e1-267e7
[33]   A comparison between microsatellite analysis and cytology of urine for the detection of bladder cancer [J].
Zhang, JJ ;
Zheng, S ;
Fan, ZB ;
Gao, YN ;
Di, XB ;
Wang, D ;
Xiao, ZJ ;
Li, CL ;
An, Q ;
Cheng, SJ .
CANCER LETTERS, 2001, 172 (01) :55-58
[34]   The impact of orthotopic neobladder vs ileal conduit urinary diversion after cystectomy on the survival outcomes in patients with bladder cancer: A propensity score matched analysis [J].
Su, Xiaohong ;
Wu, Kaihui ;
Wang, Shuo ;
Su, Wei ;
Li, Chuanyin ;
Li, Bingkun ;
Mao, Xiangming .
CANCER MEDICINE, 2020, 9 (20) :7590-7600
[35]   Efficacy and safety of radical cystectomy with ileal conduit for muscle-invasive bladder cancer in the elderly: a multicenter retrospective study [J].
Zhang, Heqian ;
Li, Anrui ;
Wang, Wentao ;
Xu, Songlin ;
Li, Changfu ;
Teng, Lichen .
FRONTIERS IN ONCOLOGY, 2024, 14
[36]   Adenocarcinoma of the Ileal Conduit in a Patient Born With Classic Bladder Exstrophy [J].
Ko, Joan S. ;
Di Carlo, Heather N. ;
Gupta, Angela D. ;
Ross, Ashley E. ;
Eckhauser, Frederic E. ;
Bivalacqua, Trinity J. .
UROLOGY CASE REPORTS, 2013, 1 (01) :5-6
[37]   Ureteroileal anastomosis-associated complications of radical cystectomy with ileal conduit in bladder cancer treatment [J].
Rumyantseva, D. I. ;
Mamizhev, E. M. ;
Krotov, N. F. ;
Shchekuteev, N. A. ;
Karaseva, M. E. ;
Semeyko, D. P. ;
Bashmakova, Ya. P. ;
Nosov, A. K. .
ONKOUROLOGIYA, 2024, 20 (03) :104-116
[38]   CXCL1 is elevated in the urine of bladder cancer patients [J].
Burnier, Andre ;
Shimizu, Yoshiko ;
Dai, Yunfeng ;
Nakashima, Masakazu ;
Matsui, Yoshiyuki ;
Ogawa, Osamu ;
Rosser, Charles J. ;
Furuya, Hideki .
SPRINGERPLUS, 2015, 4
[39]   Imperative cystectomy in patients at risk. Ileal conduit or ureterocutaneostomy? [J].
Degener, S. ;
Brandt, A. S. ;
Lazica, D. A. ;
von Rundstedt, F. -C. ;
Mathers, M. J. ;
Roth, S. .
UROLOGE, 2012, 51 (09) :1220-+
[40]   Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer [J].
Dugas, Sarah G. ;
Muller, David C. ;
Le Magnen, Clementine ;
Federer-Gsponer, Joel ;
Seifert, Hans-Helge ;
Ruiz, Christian ;
Prince, Spasenija Savic ;
Vlajnic, Tatjana ;
Zellweger, Tobias ;
Mertz, Kirsten D. ;
Bacon, Jack V. W. ;
Wyatt, Alexander W. ;
Rentsch, Cyrill A. ;
Bubendorf, Lukas .
CANCER CYTOPATHOLOGY, 2019, 127 (09) :578-585